Showing results (71-80 of 209) with videos related to
Sort By:
Pageof 21
Frontiers in Oncology|October 24, 2022
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implicationsSyed M Faisal, Andrea Comba, Maria L Varela, et al.Oncoimmunology|February 6, 2018
Melanoma induced immunosuppression is mediated by hematopoietic dysregulationNeha Kamran, Youping Li, Maria Sierra, et al.Human Gene Therapy Methods|April 9, 2016
Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma ModelNathan VanderVeen, Nicholas Raja, Elizabeth Yi, et al.Expert Opinion on Biological Therapy|March 14, 2017
Single vs. combination immunotherapeutic strategies for gliomaMayuri Chandran, Marianela Candolfi, Diana Shah, et al.Trends in Cancer|October 11, 2024
Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implicationsSantiago Haase, Stephen Carney, Maria Luisa Varela, et al.Handbook of Clinical Neurology|September 28, 2024
Cell and gene therapy in neuro-oncologyMaria Luisa Varela, Andrea Comba, Syed M Faisal, et al.The American Journal of Pathology|July 25, 2009
Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cellsCarlos Barcia, Aurora Gómez, José M Gallego-Sanchez, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|April 16, 2019
Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cellsMulu Geletu, Zaid Taha, Rozanne Arulanandam, et al.Expert Opinion on Biological Therapy|December 13, 2022
Gene Therapy for High Grade Glioma: The Clinical ExperienceMaria Luisa Varela, Andrea Comba, Syed M Faisal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial designYohei Mineharu, Gwendalyn D King, A K M G Muhammad, et al.Pageof 21